Ariad Pharmaceuticals, Inc. (ARIA) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $24.82 --0%
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income (loss) per share - basic: -0.14
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) reported Q3 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $26.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
